Study of Celebrex (Celecoxib) in Patients With Recurrent Respiratory Papillomatosis

NCT00571701 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Respiratory Papillomatosis

Interventions

DRUG: celebrex (celecoxib)
DRUG: placebo

Sponsor

Northwell Health

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]